You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Healthera secures £2m strategic investment to accelerate digital pharmacy platform growth and North American expansion
- 2. RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING'S SYNDROME
- 3. Transcriptome sequencing revealed that lymph node metastasis of papillary thyroid microcarcinoma is associated with high THBS4 expression and PDGFRA+ cancer-associated fibroblasts
- 4. SECuRE trial update: First patient treated in the Phase II Cohort Expansion
- 5. Temporal dynamics of lymphocytes in prostate cancer patients treated with proton therapy
- 6. Meta-analysis of medical cannabis outcomes and associations with cancer
- 7. Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
- 8. Identifying antisense oligonucleotides for targeted inhibition of insulin receptor isoform A
- 9. Study shows how new antibody therapy works against ovarian cancer
- 10. Disrupting calcium homeostasis and glycometabolism in engineered lipid-based pharmaceuticals propel cancer immunogenic death
Last updated at 20:50 GMT
Hot News Makers
Health/Pharma Companies
-
302963.79
-
25504.32
-
11819.22
-
11499.02
-
11251.24
-
9042.48
-
6732.06
-
5654.62
-
4642.97
-
4276.62
Drugs, Treatments, Trials
-
24575.70
-
9080.84
-
8736.78
-
8222.79
-
7566.91
-
6904.69
-
6282.56
-
4937.51
-
4638.65
-
4612.04
Last updated at 20:10 GMT
